Durvalumab, gemcitabine and cisplatin continue to show clinically meaningful long-term survival in biliary tract cancer patients
Ms Martine Frouws presents, at a press conference at ECC 2015, the findings of a large study that has shown that aspirin improves survival in patients with tumours situated throughout the gastrointestinal tract
Read the news story or watch the interview for more.
Durvalumab, gemcitabine and cisplatin continue to show clinically meaningful long-term survival in biliary tract cancer patients
Pembrolizumab combined with xelox and bevacizumab shows higher efficacy than standard therapeutic regimen in mCRC
Paclitaxel and ramucirumab switch maintenance therapy prolongs survival in HER2-negative advanced GEJ cancer
Immunotherapy significantly increases the number of patients free from bowel cancer
Nivolumab plus ipilimumab improves on chemo in previously untreated MSI-H/dMMR mCRC
ESMO 2023: Highlights and analysis
Active surveillance for oesophageal cancer shows improved HRQoL compared to standard surgery
OncoAlert Round Up for August 4th - 10th, 2023
OncoAlert round up July 28th to August 3rd, 2023